Tenders Are Invited For Procurement Of Rivaroxaban And Denosumab Medicinal Products For The Period 1 September 2026-31 December 2027

The Subject Of The Acquisition Are Rivaroxaban Capsules And Tablets 10 Mg, 15 Mg And 20 Mg (Atc: B01af01) And Denosumab Injection Solutions (Atc: M05bx04) Licensed For Sale In Finland. Partial Offers Are Taken Into Account On A Product-By-Product Basis So That The Bidder Has The Opportunity To Participate In The Tender By Offering One Or More Products In Either One Or Both Parts. A More Detailed Description Of The Procurement Can Be Found In The Tender Documents. The Procurement Ring Includes The Welfare Regions Of Pirkanmaa, Etelä Ostrobothnia And Kanta-Häme. The Joint Procurement Is Carried Out On Behalf Of The Welfare Regions Of Pirkanmaa, Etelä Ostrobothnia And Kanta-Häme By The Hospital Pharmacy Of The Pirkanmaa Welfare Region. The Tender Is Submitted Electronically At The Kilpo Competition Portal (Www.Kilpo.Fi). Instructions For Registering A New Company To The Kilpo Competition Portal Can Be Found On The Website Of The Pirkanmaa Welfare Area Hospital Pharmacy Www.Sairaala-Apteekki.Fi/Laakehankinta.